We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI System Quantifies Lung Lesions and Airway Volumes on CT Imaging in IPF Patients

By MedImaging International staff writers
Posted on 11 Apr 2022
Image: Novel AI-based technology for chest CT analysis of idiopathic pulmonary fibrosis (Photo courtesy of Unsplash)
Image: Novel AI-based technology for chest CT analysis of idiopathic pulmonary fibrosis (Photo courtesy of Unsplash)

There is a growing need to accurately estimate the prognosis of idiopathic pulmonary fibrosis (IPF) in clinical practice, given the development of effective drugs for treating IPF. Scientists have developed an artificial intelligence (AI)-based image analysis software to detect parenchymal and airway abnormalities on computed tomography (CT) imaging of the chest and to explore their prognostic importance in patients with IPF.

Scientists from the Kyoto University (Kyoto, Japan) developed the novel AI-based quantitative CT image analysis software (AIQCT) by applying 304 high-resolution CT (HRCT) scans from patients with diffuse lung diseases as the training set. AIQCT automatically categorized and quantified 10 types of parenchymal patterns as well as airways, expressing the volumes as percentages of the total lung volume. To validate the software, the area percentages of each lesion quantified by AIQCT were compared with those of the visual scores using 30 plain high-resolution CT images with lung diseases. In addition, three-dimensional analysis for similarity with ground truth was performed using HRCT images from 10 patients with IPF. AIQCT was then applied to 120 patients with IPF who underwent HRCT scanning of the chest at our institute. The associations between the measured volumes and survival were analyzed.

The scientists found that the correlations between AIQCT and the visual scores were moderate to strong (correlation coefficient 0.44–0.95) depending on the parenchymal pattern. The Dice indices for similarity between AIQCT data and ground truth were 0.67, 0.76, and 0.64 for reticulation, honeycombing, and bronchi, respectively. During a median follow-up period of 2,184 days, 66 patients died, and one underwent lung transplantation. In multivariable Cox regression analysis, bronchial volumes (adjusted hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.16–1.53) and normal lung volumes (adjusted HR, 0.97; 95% CI, 0.94–0.99) were independently associated with survival after adjusting for the gender-age-lung physiology stage of IPF.

Based on their findings, the scientists concluded that their newly-developed AI-based image analysis software successfully quantified parenchymal lesions and airway volumes. According to the scientists, bronchial and normal lung volumes on HRCT imaging of the chest can provide additional prognostic information on the gender-age-lung physiology stage of IPF.

Related Links:
Kyoto University 

Ultrasonic Pocket Doppler
SD1
Ultrasound Imaging System
P12 Elite
Portable X-ray Unit
AJEX140H
Silver Member
X-Ray QA Meter
T3 AD Pro

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.